Medium-term. results of heart transplantation using older donor organs

Background: Donor heart shortage has necessitated the expansion of the dono r pool by the use of older hearts. Patients and Methods: In a 13-year period, 1,070 heart transplants were per formed in 1,035 adults at the German Heart Institute Berlin. We divided the patients into 3 groups: Group I, donor age <35 years (n = 524); Group II, donor age 35 to 50 years (n = 379); Group III, donor age >50 years (n = 167 ). We analyzed post-operative mortality (up to 30 days), cumulative surviva l rates, cardiac dependent morbidity, and changes in the left/right ventric ular ejection fraction as well as freedom from cytomegalovirus infection an d freedom from acute rejection episodes grade greater than or equal to2 (In ternational Society for Heart and Lung Transplantation). We also calculated the rate of cardiac interventions per patient in the groups. Results: Recipients in Group III were significantly older, compared with Gr oups I and II. The post-operative mortality was 16.8% in Group I, 29.8% in Group II, and 23.4% in Group III. The differences were significant (p = 0.0 0001) between Group I and Group II. The long-term cumulative survival rates were significantly better in Group I when compared with Groups II and III (p < 0.00001, p = 0.014), but it did not differ between Groups II and III ( p = 0.18). However, cardiac morbidity in Groups I and II was significantly lower when compared with Group III (p = 0.0009, p = 0.037). Mean left and r ight ventricular ejection fraction was >55% and did not significantly chang e in groups for up to 10 years. Freedom from cytomegalovirus infection was not significantly different between Groups IT and III (p = 0.09). Significa ntly fewer percutaneous transluminal coronary angioplasties were performed in Group I, but comparable numbers were carried out in Groups II and III (p = 0.53). For retransplantation a similar situation occurred. Conclusion: We did not find significant differences in the mid-term follow- up between patients who received hearts from 35- to 50-year-old donors and from those who had received hearts from donors >50 years, despite increased cardiac morbidity in Group III. Close monitoring of the coronary situation after heart transplantation and expanded indications for revascularization in Group III makes heart transplantation with older hearts a suitable opti on to save the lives of patients in end-stage heart failure.